The mechanisms underlying cardiovascular toxicity of AIs include the inhibition of vasodilation by reducing nitric oxide (NO) levels, the induction of arteriolar vasoconstriction by increasing production of endothelin 1, and the development of kidney damage through capillary rarefaction and reduction of neovascularization (27, 28). This evidence concerns the gene EDN1 and Nephropathy.